GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Caladrius Biosciences Inc. (CLBS) [hlAlert]

NeoStem, Inc. (NeoStem) is engaged in a platform business of operating a commercial autologous (donor and recipient are the same) adult stem cell bank and in pre-disease collection, processing and long-term storage of stem cells from adult donors that they can access for their own future medical treatment. The
Company manages a network of adult stem cell collection centers throughout the United States. It also entered the research and development arenas, through the acquisition of a worldwide license to an early-stage technology to identify and isolate rare stem cells from adult human bone marrow, called VSEL (very small embryonic-like) stem cells. VSELs have many physical characteristics typically found in embryonic stem cells, including the ability to differentiate into specialized cells found in substantially all the different types of cells and tissue that make up the body. In October 2009, NeoStem, Inc. completed the acquisition of China Biopharmaceuticals Holdings, Inc.
.
( Total: 10 Current Stock Recommendations )
Caladrius Biosciences Inc.   (10)
Hold Buy 90%
Related companies
Dialysis ...   (2)
Buy 100%
Capital Senior ...   (7)
Buy 100%
Bioscrip, Inc.   (9)
Buy 100%
Transcend Services, ...   (1)
Buy 100%
America Service ...   (2)
Buy 100%
Adcare Health ...   (2)
Buy 100%
Hanger Orthopedic ...   (7)
Buy 100%
Enzo Biochem, Inc.   (2)
Buy 100%
VIRTUAL RADIOLOGIC   (3)
Buy 100%
Concord Medical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold CLBS

Rating:
Buy CLBS
down 46.66 %

Rating:
Buy CLBS
down 67.59 %

Rating:
Buy CLBS
down 85.68 %
NEOSTEM INC. (NBS) rated Buy with price target $14 by MLV & Co
Tuesday,  Nov 18, 2014  12:25 PM ET

Rating:
Buy CLBS
down 95.73 %

Rating:
Buy CLBS
down 82.97 %

Rating:
Buy CLBS
down 75.84 %

Rating:
Buy CLBS
NEOSTEM INC. (NBS) rated Buy with price target $16 by MLV & Co
Thursday,  Sep 12, 2013  9:25 AM ET

Rating:
Buy CLBS
down 85.68 %
NEOSTEM INC. (NBS) rated Buy with price target $16 by MLV & Co
Thursday,  Sep 12, 2013  8:25 AM ET

Rating:
Buy CLBS
down 75.84 %

Rating:
Buy CLBS
down 82.97 %

Rating:
Buy CLBS
down 82.97 %

Rating:
Buy CLBS
down 80.89 %

Rating:
Buy CLBS
down 82.97 %
NEOSTEM INC. (NBS) upgraded to Speculative Buy by WBB Securities
Tuesday,  Aug 16, 2011  9:25 AM ET

Rating:
Buy CLBS
down 90.30 %

Your Recent Stocks
SymbolLastChange
CLBS 0.55 down  -56.95 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy